Get started
Author

Rufei Liu

Observed name: R. Liu
ORCID: 0009-0003-8030-0475
Observed ORCID: 0009-0003-8030-0475
OpenAlex ID: A5039542118
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
2024 · Ting Yu, Zhaoyun Liu, et al. · Cancer Letters · 60
The Association Between Neutrophil‐Percentage‐to‐Albumin Ratio ( NPAR ) and Mortality Among Individuals With Cancer: Insights From National Health and Nutrition Examination Survey
2025 · Xinyang Li, Meng Wu, et al. · Cancer Medicine · 26
PDF
Association between HDL‐C and intensive blood pressure control in patients with hypertension: A post‐hoc analysis of SPRINT
2024 · Rufei Liu, Wenli Cheng · Journal of Clinical Hypertension · 8
PDF
P6462Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding scores in ACS patients undergoing PCI: insights from a cohort of 4939 patients in China
2017 · R. Liu, Nie SP · European Heart Journal · 3
The Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Cancer Mortality: Insights from National Health and Nutrition Examination Survey
2023 · Xinyang Li, Meng Wu, et al. · Research Square · 1
PDF
Antihypertensive Efficacy, Safety, and Adherence After Switching From a Free Combination of Bisoprolol/Metoprolol and Amlodipine to Bisoprolol/Amlodipine FDC Tablets (5/5 mg) in Chinese Patients With Hypertension
2026 · Ning Wang, Xiaoyang Zhou, et al. · Journal of Clinical Hypertension
Switching to Bisoprolol/amlodipine Spc in Hypertension: a Chinese Real-world Study
2026 · Rufei Liu, Wenli Cheng · Journal of Hypertension
Triglyceride and Glucose Index and Sex Differences in Relation to Cognitive Impairment in Hypertensive Patients without Diabetes
2023 · Rufei Liu, Wenli Cheng · medRxiv
PDF
Works count: 8
Citation count: 98
H-index: 3
I10-index: 2
Year
Topic
Type